Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
bifidobacterium infantis (1 trial)
nitazoxanide (Alinia) (1 trial)
pancrelipase (creon) (1 trial)
influenza vaccine, recombinant hemagglutinin (1 trial)
fedovapagon (1 trial)
Influenza, Human (Phase 3)
Irritable Bowel Syndrome (Phase 4)
Nocturia (Phase 2)
Syndrome (Phase 4)
Trials (3 total)
Trial APIs (5 total)